explain epidemiologial studies method according to k park book of preventive and social medicine in an easy way to understand so that i can write that for tomorrows exam

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web

K Park epidemiological studies methods types preventive social medicine

Now I have enough to write a comprehensive, exam-ready explanation. K Park's Textbook of Preventive and Social Medicine is the standard reference for this topic. Here's the complete breakdown:

Epidemiological Study Methods — K Park (PSM)

What is an Epidemiological Study?

A study that examines the distribution (who, where, when) and determinants (why, how) of disease in populations — to understand causes and plan prevention.

CLASSIFICATION AT A GLANCE

EPIDEMIOLOGICAL STUDIES
│
├── A. OBSERVATIONAL STUDIES (no intervention)
│   ├── 1. Descriptive Studies
│   │   ├── Case Reports / Case Series
│   │   ├── Cross-Sectional (Prevalence) Study
│   │   └── Ecological (Correlational) Study
│   │
│   └── 2. Analytical Studies
│       ├── Case-Control Study (retrospective)
│       └── Cohort Study (prospective / retrospective)
│
└── B. EXPERIMENTAL STUDIES (intervention done)
    ├── Randomized Controlled Trial (RCT)
    ├── Field Trial
    └── Community Trial

A. OBSERVATIONAL STUDIES

1. DESCRIPTIVE STUDIES

Describe the occurrence of disease by Person, Place, Time — they answer "What is happening?" and generate hypotheses.

(a) Case Report / Case Series

  • What it is: Detailed description of 1 patient (case report) or a small group (case series).
  • Purpose: Raises an alarm; generates hypothesis.
  • Example: First AIDS cases described in homosexual men (1981) → led to hypothesis.
  • Limitation: No comparison group; cannot prove causation.

(b) Cross-Sectional Study (Prevalence Study / Survey)

  • What it is: A snapshot — disease and exposure measured at the same point in time in a defined population.
  • Purpose: Measures prevalence; useful for planning health services.
  • Example: A survey measuring prevalence of hypertension in a district on a single day.
FeatureDetails
DirectionNo direction (snapshot)
MeasuresPrevalence
TimeShort (one point in time)
CostModerate
CausationCannot prove (chicken-and-egg problem)
  • Advantage: Quick, cheap, gives prevalence data.
  • Limitation: Cannot determine cause-effect; unsuitable for rare or acute diseases.

(c) Ecological (Correlational) Study

  • What it is: Compares disease rates across whole populations (not individuals) with exposure data.
  • Example: Countries with high fat intake vs. countries with high breast cancer rates → correlation found.
  • Limitation: Ecological fallacy — what is true for a population may not be true for an individual.

2. ANALYTICAL STUDIES

These test a hypothesis — they answer "Why is it happening?"

(a) Case-Control Study (Retrospective)

Direction: Present → Past (look backwards)
  • Cases = people who already have the disease.
  • Controls = people without the disease (similar in other ways).
  • Both groups are asked: "Were you exposed to the risk factor in the past?"
  • Measure of association: Odds Ratio (OR)
         Cases   Controls
Exposed    a        b
Not Exp    c        d

Odds Ratio = (a×d) / (b×c)
Example: Study lung cancer patients (cases) vs. non-cancer people (controls) → ask both about past smoking.
FeatureDetails
DirectionRetrospective (past exposure)
Starts withDisease (cases)
MeasuresOdds Ratio (OR)
Best forRare diseases
TimeShort (relatively)
CostLess expensive
Advantages:
  • Good for rare diseases
  • Quick, inexpensive
  • Can study multiple exposures for one disease
Disadvantages:
  • Subject to recall bias (patients may remember differently)
  • Cannot calculate incidence or relative risk directly
  • Selection of controls is difficult
  • Temporal relationship hard to establish

(b) Cohort Study (Prospective / Longitudinal / Follow-up Study)

Direction: Present → Future (look forward)
  • Take a group of disease-free people.
  • Divide them into exposed and non-exposed.
  • Follow up over time → see who develops the disease.
  • Measure of association: Relative Risk (RR) = Incidence Rate Ratio
              Disease   No Disease
Exposed         a           b
Not Exposed     c           d

Incidence in exposed    = a/(a+b)
Incidence in unexposed  = c/(c+d)
Relative Risk (RR)      = [a/(a+b)] / [c/(c+d)]
Example: Follow 10,000 smokers and 10,000 non-smokers for 20 years → compare lung cancer rates.
FeatureDetails
DirectionProspective (forward)
Starts withExposure (no disease yet)
MeasuresRelative Risk (RR), Incidence
Best forCommon diseases
TimeLong (years)
CostExpensive
Advantages:
  • Can calculate incidence and relative risk
  • Temporal relationship clearly established (cause before effect)
  • Can study multiple outcomes from one exposure
  • Less recall bias
Disadvantages:
  • Very expensive and time-consuming
  • Large numbers needed
  • Loss to follow-up (attrition bias)
  • Not suitable for rare diseases
Historical Cohort (Retrospective Cohort): Uses old records. Exposure was in the past, disease identified now. Faster and cheaper than prospective.

Quick Comparison: Case-Control vs Cohort

FeatureCase-ControlCohort
DirectionBackward (past)Forward (future)
Starts withDiseaseExposure
MeasureOdds RatioRelative Risk
Best forRare diseaseCommon disease, rare exposure
TimeShortLong
CostCheapExpensive
Main biasRecall biasLoss to follow-up

B. EXPERIMENTAL STUDIES

The investigator intervenes — applies treatment or preventive measure and observes outcomes. These can establish causation.

(1) Randomized Controlled Trial (RCT) — Clinical Trial

  • Individuals randomly assigned to intervention (treatment) group or control (placebo/standard) group.
  • Randomization eliminates selection bias and balances confounders.
  • Blinding: Single-blind (patient unaware), Double-blind (patient + investigator unaware), Triple-blind (+ analyst unaware).
  • Gold standard for testing therapeutic interventions.
  • Example: Testing a new drug for TB — half get the drug, half get placebo.

(2) Field Trial

  • Conducted in the field (community), not a hospital.
  • Participants are healthy people at risk (not yet diseased).
  • Purpose: Test preventive measures (vaccines, prophylactic drugs).
  • Example: Salk polio vaccine trial — vaccine given to healthy children in field.
  • Very expensive; requires huge numbers.

(3) Community Trial (Community Intervention Study)

  • The community (not the individual) is the unit of randomization/intervention.
  • Example: Fluoridation of water supply in some towns vs. not in others → compare dental caries rates.
  • Used when individual randomization is not feasible.

SPECIAL CONCEPTS TO REMEMBER

Attributable Risk (AR)

  • How much of the disease in exposed people is due to the exposure?
  • AR = Incidence in exposed − Incidence in unexposed

Population Attributable Risk (PAR)

  • How much disease in the whole population is due to the exposure?
  • Important for public health policy.

Bias Types (often asked)

BiasDefinitionIn which study
Recall biasCases remember exposure more than controlsCase-control
Selection biasNon-representative sample selectedAny study
Observation biasObserver measures differently in groupsAny
Berkson's biasHospital controls differ from general populationCase-control
Neyman biasPrevalent cases differ from incident casesCross-sectional

ONE-LINE SUMMARY FOR QUICK REVISION

StudyKey wordDirectionMeasure
Case ReportDescriptionNoneNone
Cross-SectionalSnapshot/PrevalenceNonePrevalence
EcologicalPopulation correlationNoneCorrelation
Case-ControlRetrospectivePast ← PresentOdds Ratio
CohortProspectivePresent → FutureRelative Risk
RCTRandomized trialPresent → FutureRelative Risk
Field TrialVaccine/prevention in fieldPresent → FutureEfficacy
Community TrialWhole community interventionPresent → FutureRate difference

EXAM TIPS (K Park Specific)

  1. Definition of epidemiology (John Last): "Study of the distribution and determinants of health-related states or events in specified populations and the application of this study to control health problems."
  2. Case-control is best for rare diseases; cohort is best for rare exposures.
  3. Only experimental studies can establish causation.
  4. Cross-sectional gives prevalence; cohort gives incidence.
  5. Odds ratio approximates relative risk when disease is rare (rare disease assumption).
  6. The strongest evidence hierarchy: Systematic Review/Meta-analysis > RCT > Cohort > Case-Control > Cross-Sectional > Case Report.

Good luck for your exam tomorrow! Focus especially on the case-control vs cohort comparison table and the measures of association (OR vs RR) — those are the most frequently asked points in PSM exams.
This is a shared conversation. Sign in to Orris to start your own chat.